Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome

MLA

Witold Szkróbka, et al. “Correction to: The Impact of Atorvastatin on Cardiometabolic Risk Factors in Brothers of Women with Polycystic Ovary Syndrome.” Pharmacological Reports, vol. 73, no. 5, May 2021, p. 1481. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4ca1491b93096b757d93aad1f41b20ef&authtype=sso&custid=ns315887.

APA

Witold Szkróbka, Robert Krysiak, & Bogusław Okopień. (2021). Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome. Pharmacological Reports, 73(5), 1481.

Chicago

Witold Szkróbka, Robert Krysiak, and Bogusław Okopień. 2021. “Correction to: The Impact of Atorvastatin on Cardiometabolic Risk Factors in Brothers of Women with Polycystic Ovary Syndrome.” Pharmacological Reports 73 (5): 1481. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4ca1491b93096b757d93aad1f41b20ef&authtype=sso&custid=ns315887.